Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Clinical trial NCT03439254 · COMPLETED
Trial details
- NCT number
- NCT03439254
- Sponsor
- Intercept Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-30
- Primary completion
- 2022-09-08
- Enrollment
- 919
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.